GB9709815D0 - Therapeutic method - Google Patents
Therapeutic methodInfo
- Publication number
- GB9709815D0 GB9709815D0 GB9709815A GB9709815A GB9709815D0 GB 9709815 D0 GB9709815 D0 GB 9709815D0 GB 9709815 A GB9709815 A GB 9709815A GB 9709815 A GB9709815 A GB 9709815A GB 9709815 D0 GB9709815 D0 GB 9709815D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- therapeutic method
- npy
- neuropeptide
- migraine
- agonists
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002560 therapeutic procedure Methods 0.000 title 1
- 101710151321 Melanostatin Proteins 0.000 abstract 1
- 208000019695 Migraine disease Diseases 0.000 abstract 1
- 102400000064 Neuropeptide Y Human genes 0.000 abstract 1
- 239000000556 agonist Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 206010027599 migraine Diseases 0.000 abstract 1
- URPYMXQQVHTUDU-OFGSCBOVSA-N nucleopeptide y Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 URPYMXQQVHTUDU-OFGSCBOVSA-N 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
Abstract
Compounds which are agonists of the neuropeptide Y (NPY) receptor, including NPY itself, are effective agents in the treatment and/or prevention of migraine and associated conditions.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9709815A GB9709815D0 (en) | 1997-05-14 | 1997-05-14 | Therapeutic method |
| GB9809555A GB2324961A (en) | 1997-05-14 | 1998-05-05 | Use of neuropeptide Y receptor agonists for treating migraine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9709815A GB9709815D0 (en) | 1997-05-14 | 1997-05-14 | Therapeutic method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB9709815D0 true GB9709815D0 (en) | 1997-07-09 |
Family
ID=10812313
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB9709815A Pending GB9709815D0 (en) | 1997-05-14 | 1997-05-14 | Therapeutic method |
| GB9809555A Withdrawn GB2324961A (en) | 1997-05-14 | 1998-05-05 | Use of neuropeptide Y receptor agonists for treating migraine |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB9809555A Withdrawn GB2324961A (en) | 1997-05-14 | 1998-05-05 | Use of neuropeptide Y receptor agonists for treating migraine |
Country Status (1)
| Country | Link |
|---|---|
| GB (2) | GB9709815D0 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0102855D0 (en) * | 2001-08-27 | 2001-08-27 | Astrazeneca Ab | Method of treatment |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997020823A2 (en) * | 1995-12-01 | 1997-06-12 | Novartis Ag | 2-amino quinazoline derivatives as npy receptor antagonists |
-
1997
- 1997-05-14 GB GB9709815A patent/GB9709815D0/en active Pending
-
1998
- 1998-05-05 GB GB9809555A patent/GB2324961A/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| GB2324961A (en) | 1998-11-11 |
| GB9809555D0 (en) | 1998-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA34466C2 (en) | Agent for non-systemic control of parasites | |
| PL327934A1 (en) | Novel substituted imidazole compounds | |
| AP1869A (en) | b2- Adrenergic receptor agonists. | |
| MY114014A (en) | Imidazole compounds, compositions and use | |
| DK1039912T3 (en) | Angiostatic agents and preparations for the treatment of GLC1A glaucoma | |
| PL328858A1 (en) | Immunogenous peptides | |
| MX9702170A (en) | Use of aromatase inhibitors in the preparation of a drug for treating a relative androgen deficiency in men. | |
| CY2431B1 (en) | Novel phenanthridines substituted in the 6 position. | |
| PL367065A1 (en) | Use of osteopontin for the treatment and/or prevention of neurologic diseases | |
| ZA200003236B (en) | Combination therapy for the treatment of migraine. | |
| DE69120287D1 (en) | Aminosulfonylharnstoff-acat-inhibitoren | |
| IL144199A0 (en) | Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions | |
| UA50761C2 (en) | Method for prevention and/or treatment of heart failure and ventricular dysfunction in warm-blooded animals, pharmaceutical formulation | |
| HU9700024D0 (en) | Imidazopyridin-azolidinones | |
| GB9709815D0 (en) | Therapeutic method | |
| GB9916729D0 (en) | Fuller for the treatment of leather,pelts and the like | |
| GB9805559D0 (en) | A combination of therapeutic agents | |
| ZA200002338B (en) | Combination therapy for the treatment of migraine. | |
| ZA200003235B (en) | Combination therapy for the treatment of migraine. | |
| BG104259A (en) | Derivatives of 4-cyano-4-deformylsordaricin | |
| IL130642A0 (en) | N-(pyridinylamino)isoindolines and related compounds | |
| IL139303A0 (en) | Treatment of arthritis and other similar conditions | |
| ZA200002343B (en) | Combination therapy for the treatment of migraine. | |
| TR200003084T2 (en) | Paroxetine ascorbate | |
| AP2000001958A0 (en) | Paroxetine 10-camphorsulfornate for treatment of CNS disorders. |